Vaxigrip Junior Injektionsvätska, suspension

Country: Sweden

Language: Swedish

Source: Läkemedelsverket (Medical Products Agency)

Active ingredient:

influensavirus A/California/7/2009 (H1N1)pdm09-deriverad stam (NYMC X-179A), spjälkat virus, inaktiverat; influensavirus A/Texas/50/2012 (H3N2)-deriverad stam (NYMC X-223A), spjälkat virus, inaktiverat; influensavirus B/Massachusetts/2/2012, spjälkat virus, inaktiverat

Available from:

Sanofi Pasteur MSD

ATC code:

J07BB02

INN (International Name):

the influenza virus A/California/7/2009 (H1N1)pdm09-derived strain (NYMC X-179A), spjälkat virus, inactivated; influenza virus, A/Texas/50/2012 (H3N2)-derived strain (NYMC X-223A), spjälkat virus, inactivated; influenza virus B/Massachusetts/2/2012, spjälkat virus, inactivated

Pharmaceutical form:

Injektionsvätska, suspension

Composition:

influensavirus A/California/7/2009 (H1N1)pdm09-deriverad stam (NYMC X-179A), spjälkat virus, inaktiverat 7,5 mikrog Aktiv substans; influensavirus A/Texas/50/2012 (H3N2)-deriverad stam (NYMC X-223A), spjälkat virus, inaktiverat 7,5 mikrog Aktiv substans; influensavirus B/Massachusetts/2/2012, spjälkat virus, inaktiverat 7,5 mikrog Aktiv substans

Prescription type:

Receptbelagt

Therapeutic area:

spjälkat virus eller ytantigen

Authorization status:

Avregistrerad

Authorization date:

1999-05-21